- | Study                     | Mean Age (years) | Female Gender (%) | Time to Presentation in STEMI (min) | CS (%) | STEMI vs NSTEMI (%)      | Thrombolysis (%) | Overall Mortality vs STEMI vs NSTE-ACS (%) | CAG and PCI (%)         |
|----------------------------|------------------|-------------------|-------------------------------------|--------|--------------------------|-----------------|-------------------------------------------|-------------------------|
| CREATE (6) 2001–2005 n-20937 | 57.5             | 23.6              | 300                                 | NA     | 60.6% vs 39.4%            | 59              | 6.7% vs 8.6% vs 3.8%                     | 23.2% and 2.9%          |
| KERALA ACS (7) 2007–2009 n-25748 | 60.4         | 22.6              | NA                                  | 1.9%   | 37% vs 31%                | 41.4            | 3.9% vs 8.2% vs 1.8%                     | 19.5% vs 11.9%          |
| DEMAT (15) 2007–2008 n-1565   | 59.2            | 21%               | NA                                  | NA     | 51.6% vs 48.4%            | 45              | 2.04% vs NA                              | NA vs 44.9%             |
| GMC North east (16) 2011–2012 n-704 | 56.5       | 28.1              | 700                                 | 12.3%  | 72.4% vs 27.8%            | 39              | 10.2% vs 11.7% vs 6.8%                   | 46.3% vs 12.7%          |
| HP-ACS (8) 2012–2014 n-5807  | 60.9             | 21.9              | 780                                 | 10.2%  | 45.5% vs 54.5%            | 35.6            | 7.6% vs 10.8% vs 5%                      | 1.4% vs 0.6%            |
| PGIMER ACS 2018–2019 n-1203  | 58.44            | 25.4              | 600                                 | 18%    | 69.9% vs 30.1%            | 52              | 7.6% vs 8.9% vs 4.7%                     | 88.3% vs 60.9%          |
